For Media
Connect With an Expert
BrightFocus Foundation’s in-house team of scientists are available for media interviews about Alzheimer’s disease, macular degeneration, and glaucoma. To arrange an interview, please contact Julia Roth at jroth@brightfocus.org.
Diane Bovenkamp, PhD, Vice President, Scientific Affairs
Diane Bovenkamp, PhD, Vice President of Scientific Affairs, is the chief scientist at BrightFocus Foundation, overseeing global operations of the organization’s research programs. She serves as the scientific liaison in local, national, and international forums, and identifies and develops new research initiatives, partnerships, and funding policies consistent with the mission of BrightFocus.
Dr. Bovenkamp obtained her PhD in biochemistry from Queen’s University in Kingston, Ontario, Canada, discovering and studying Eph receptors in angiogenesis and neural development in zebrafish and mice. She completed a postdoctoral fellowship in the Vascular Biology Program at Boston Children’s Hospital/Harvard Medical School, isolating and characterizing zebrafish neuropilins. Dr. Bovenkamp conducted further research at the Johns Hopkins University Bayview Proteomics Center in the Division of Cardiology at Johns Hopkins School of Medicine, using proteomic techniques for biomarker detection in human serum.
Sharyn Rossi, PhD, Senior Director of Neuroscience Programs
Dr. Sharyn Rossi received her PhD in anatomy and neurobiology from the University of California, Irvine, where she studied stem cell replacement therapies for the treatment of spinal cord injury. She continued her post-doctoral work at A.I. duPont Hospital for Children studying spinal muscular atrophy, and Johns Hopkins University, using optogenetics to investigate how transplanted stem cells integrate into brain circuitry after traumatic brain injury. Prior to joining BrightFocus, Dr. Rossi was a senior research scientist at the National Institute on Aging, using neuroimaging, light-sheet microscopy, and novel interventions to investigate changes in the brain during normal cognitive aging.
Latest Research News from BrightFocus-Funded Scientists
Understanding the Causes of Steroid-Induced Glaucoma
A commonly used medication is linked to increased risk of glaucoma. A BrightFocus National Glaucoma Research-funded scientist is trying to understand why.
Can Better Sleep Slow Alzheimer’s?
New BrightFocus-funded research suggests restoring sleep may help protect the brain from dementia progression, and a common insomnia drug could help lead the way.
Dr. David Abramson Receives 2026 Helen Keller Prize for Vision Research from BrightFocus Foundation and Helen Keller Foundation
A pioneering clinician-scientist at Memorial Sloan Kettering Cancer Center, Dr. Abramson has transformed understanding and treatment of eye cancers worldwide.
FDA Approves Repurposed Anti-Depressant to Treat Alzheimer’s-Associated Agitation
Auvelity, developed by Axsome Therapeutics, was approved today by the U.S. Food & Drug Administration (FDA) for the treatment of Alzheimer’s disease agitation, a common and challenging symptom that affects 40 to 60 percent of people living with Alzheimer’s.
BrightFocus Honors 5 Vision Scientists Advancing Breakthrough Eye Research
At a ceremony recognizing 2026 vision grant recipients, these prestigious awards honor five standout scientists whose work is shaping the future of prevention, treatments, and cures for macular degeneration and glaucoma—two leading causes of vision loss.
Donor Support Powers $16M+ Investment in 69 Projects Tackling Alzheimer’s, Macular Degeneration, and Glaucoma
Following a year of uncertainty surrounding federal biomedical research funding, BrightFocus Foundation provides critical support for innovative brain and eye research.
Breaking News Dispatch: Alzheimer’s Oral Therapies, Prevention Strategies, and Targeted Treatments Emerge
Get the latest research news from the 2026 International Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD) conference.
Focusing on the Future: Key Takeaways from the 2025 Glaucoma Fast Track
BrightFocus Foundation’s 2025 Glaucoma Fast Track brought together early-career and established scientists to provide a thorough overview of the biology, diagnosis, and treatment of glaucoma.
Shaping the Future of Macular Degeneration Research: Key Takeaways from the 2025 AMD Fast Track Workshop
BrightFocus Foundation’s 2025 Age-Related Macular Degeneration (AMD) Fast Track brought together early-career and established scientists to accelerate research toward a cure for AMD.
Understanding the Causes of Steroid-Induced Glaucoma
A commonly used medication is linked to increased risk of glaucoma. A BrightFocus National Glaucoma Research-funded scientist is trying to understand why.
Can Better Sleep Slow Alzheimer’s?
New BrightFocus-funded research suggests restoring sleep may help protect the brain from dementia progression, and a common insomnia drug could help lead the way.
Dr. David Abramson Receives 2026 Helen Keller Prize for Vision Research from BrightFocus Foundation and Helen Keller Foundation
A pioneering clinician-scientist at Memorial Sloan Kettering Cancer Center, Dr. Abramson has transformed understanding and treatment of eye cancers worldwide.
FDA Approves Repurposed Anti-Depressant to Treat Alzheimer’s-Associated Agitation
Auvelity, developed by Axsome Therapeutics, was approved today by the U.S. Food & Drug Administration (FDA) for the treatment of Alzheimer’s disease agitation, a common and challenging symptom that affects 40 to 60 percent of people living with Alzheimer’s.
BrightFocus Honors 5 Vision Scientists Advancing Breakthrough Eye Research
At a ceremony recognizing 2026 vision grant recipients, these prestigious awards honor five standout scientists whose work is shaping the future of prevention, treatments, and cures for macular degeneration and glaucoma—two leading causes of vision loss.
Donor Support Powers $16M+ Investment in 69 Projects Tackling Alzheimer’s, Macular Degeneration, and Glaucoma
Following a year of uncertainty surrounding federal biomedical research funding, BrightFocus Foundation provides critical support for innovative brain and eye research.
Breaking News Dispatch: Alzheimer’s Oral Therapies, Prevention Strategies, and Targeted Treatments Emerge
Get the latest research news from the 2026 International Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD) conference.
Focusing on the Future: Key Takeaways from the 2025 Glaucoma Fast Track
BrightFocus Foundation’s 2025 Glaucoma Fast Track brought together early-career and established scientists to provide a thorough overview of the biology, diagnosis, and treatment of glaucoma.
Shaping the Future of Macular Degeneration Research: Key Takeaways from the 2025 AMD Fast Track Workshop
BrightFocus Foundation’s 2025 Age-Related Macular Degeneration (AMD) Fast Track brought together early-career and established scientists to accelerate research toward a cure for AMD.
Fact Sheets
Alzheimer’s Disease Facts & Figures
Every three seconds, someone in the world develops dementia. That’s the same amount of time it takes to read this sentence out loud. Get the facts about Alzheimer’s disease—the most common form of dementia.
Macular Degeneration Facts & Figures
Advanced age-related macular degeneration (AMD) is a leading cause of irreversible blindness and visual impairment, affecting nearly 20 million U.S. adults who are living with some form of AMD.
Glaucoma Facts & Figures
More than three million Americans are living with glaucoma, a group of eye disorders that can lead to vision loss or complete blindness.
Press Releases
Dr. David Abramson Receives 2026 Helen Keller Prize for Vision Research from BrightFocus Foundation and Helen Keller Foundation
A pioneering clinician-scientist at Memorial Sloan Kettering Cancer Center, Dr. Abramson has transformed understanding and treatment of eye cancers worldwide.
BrightFocus Honors 5 Vision Scientists Advancing Breakthrough Eye Research
At a ceremony recognizing 2026 vision grant recipients, these prestigious awards honor five standout scientists whose work is shaping the future of prevention, treatments, and cures for macular degeneration and glaucoma—two leading causes of vision loss.
Donor Support Powers $16M+ Investment in 69 Projects Tackling Alzheimer’s, Macular Degeneration, and Glaucoma
Following a year of uncertainty surrounding federal biomedical research funding, BrightFocus Foundation provides critical support for innovative brain and eye research.
2025 Research Portfolios Spotlight Breakthrough Science
BrightFocus is proudly supporting 186 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.
New Public Service Campaign Encourages Eye Exams to Save Sight
BrightFocus Foundation’s new national public service announcements raise awareness of macular degeneration and glaucoma, leading causes of irreversible blindness among people age 50 and older in the U.S.
BrightFocus Foundation and Focused Ultrasound Foundation Announce Partnership to Advance Alzheimer’s Research
A three-year collaboration supports pioneering non-invasive treatment strategies for Alzheimer’s disease using focused ultrasound.
BrightFocus and Alzheimer’s Los Angeles Renew Partnership to Fund Promising Alzheimer’s Research
Ongoing collaboration advances promising Alzheimer’s drug discovery research in Southern California.
BrightFocus Foundation Awards Nearly $13M to 50 Scientists for Alzheimer’s, Macular Degeneration, and Glaucoma Research
Private research nonprofit BrightFocus Foundation today announced nearly $13 million in grants to support early investigative research into Alzheimer’s disease, macular degeneration, and glaucoma.
BrightFocus Foundation and Helen Keller Foundation Award University of Iowa Researchers 2025 Prize for Pioneering Eye Research
Drs. Val C. Sheffield and Edwin M. Stone of the University of Iowa have received the 2025 Helen Keller Prize for Vision Research for their groundbreaking work.
Dr. David Abramson Receives 2026 Helen Keller Prize for Vision Research from BrightFocus Foundation and Helen Keller Foundation
A pioneering clinician-scientist at Memorial Sloan Kettering Cancer Center, Dr. Abramson has transformed understanding and treatment of eye cancers worldwide.
BrightFocus Honors 5 Vision Scientists Advancing Breakthrough Eye Research
At a ceremony recognizing 2026 vision grant recipients, these prestigious awards honor five standout scientists whose work is shaping the future of prevention, treatments, and cures for macular degeneration and glaucoma—two leading causes of vision loss.
Donor Support Powers $16M+ Investment in 69 Projects Tackling Alzheimer’s, Macular Degeneration, and Glaucoma
Following a year of uncertainty surrounding federal biomedical research funding, BrightFocus Foundation provides critical support for innovative brain and eye research.
2025 Research Portfolios Spotlight Breakthrough Science
BrightFocus is proudly supporting 186 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.
New Public Service Campaign Encourages Eye Exams to Save Sight
BrightFocus Foundation’s new national public service announcements raise awareness of macular degeneration and glaucoma, leading causes of irreversible blindness among people age 50 and older in the U.S.
BrightFocus Foundation and Focused Ultrasound Foundation Announce Partnership to Advance Alzheimer’s Research
A three-year collaboration supports pioneering non-invasive treatment strategies for Alzheimer’s disease using focused ultrasound.
BrightFocus and Alzheimer’s Los Angeles Renew Partnership to Fund Promising Alzheimer’s Research
Ongoing collaboration advances promising Alzheimer’s drug discovery research in Southern California.
BrightFocus Foundation Awards Nearly $13M to 50 Scientists for Alzheimer’s, Macular Degeneration, and Glaucoma Research
Private research nonprofit BrightFocus Foundation today announced nearly $13 million in grants to support early investigative research into Alzheimer’s disease, macular degeneration, and glaucoma.
BrightFocus Foundation and Helen Keller Foundation Award University of Iowa Researchers 2025 Prize for Pioneering Eye Research
Drs. Val C. Sheffield and Edwin M. Stone of the University of Iowa have received the 2025 Helen Keller Prize for Vision Research for their groundbreaking work.